Adrian Filiberti

Experienced Life Science Scientist with 19+ years in Recombinant Protein Expression/Characterization, Genetic and Molecular Cell Biology, specializing in leading research and development projects to successful outcomes. Proven track record in securing significant grant funding, developing novel treatments, and transitioning projects from academia to industry. Skilled in project management under GxP standards, and adept at founding and growing biotech ventures. Committed to driving research innovation and excellence in the biotech field. To strengthen my business knowledge, I am taking a fully online MBA that I hope to complete by the end of this year.

• Researching domain. Displaying 19+ years of expertise in Recombinant Protein Expression/Characterization, Genetic and Molecular Cell Biology. Executed 11 diverse research projects, generating 25 peer-reviewed publications with 600+ citations, developing 3 novel treatments, and securing $975,794 in grants.

• Development domain. Managed the development of four cell therapy projects under strict GxP guidelines, as well as an electromechanical remote expression device. Secured $200,000 in financing to support the R&D, and transfer biotech-projects from academy to industry.

• Entrepreneurship domain. Biotechnology as a field related to business. Directed the founding of BioDare.com, contributed  on buisiness develop of robotic-crew.com and others, leveraging cross-functional team management to design and manufacture 50+ electro-mechanical machines for biotech-labs, yielding a 33% annualized ROI.

My formal education is centered on protein biochemistry, with thorough study in activity, production, molecular and functional characterization, and formulation.  Beyond my doctoral training, I have cultivated a broad foundation in biotechnology over 19+ years across two countries. This experience encompasses academic research, industrial development, clinical studies, and entrepreneurial ventures.  My work in diverse areas, including cancer biology, immunology, microbiology, vision science, molecular and cell biology, and genetic engineering, has provided me with a comprehensive perspective on the biotech sector, from fundamental research to commercial applications.